Suppr超能文献

原子工程化的铁在活性中心中的氯配位用于选择性催化 HO 分解以实现高效的抗肿瘤特异性治疗。

Atomically Engineered Chlorine Coordination of Iron in Active Centers for Selectively Catalytic HO Decomposition Toward Efficient Antitumor-Specific Therapy.

机构信息

School of Chemical Sciences and Technology, Yunnan Province Engineering Research Center of Photocatalytic Treatment of Industrial Wastewater, Yunnan University, Kunming, 650091, China.

School of Materials and Energy, Yunnan Province Engineering Research Center of Photocatalytic Treatment of Industrial Wastewater, Yunnan University, Kunming, 650091, China.

出版信息

Adv Healthc Mater. 2024 Nov;13(29):e2401267. doi: 10.1002/adhm.202401267. Epub 2024 Sep 2.

Abstract

The intervention of endogenous HO via nanozymes provides a potential antitumor-specific therapy; however, the role of the nanozyme structure in relation to the selective decomposition of HO to hydroxyl radicals (•OH) is yet to be fully understood, which limits the development of this therapeutic approaches. Herein, an iron single-atom nanozyme (Fe─NCl─C SAzyme) is reported, which is prepared through precise Fe─Cl coordination based on the construction of a characteristic Fe-containing molecule. Fe─NCl─C exhibits efficient catalytic HO decomposition (2.19 × 10 mm s), which is the highest among reported SAzymes. More importantly, it is found that HO selectively decomposed into •OH on the Fe─NCl─C surface, which is attributable to the d orbitals of the Fe active center matching the O-2p electrons of the adsorbed hydroxide (*OH) intermediate. Fe─NCl─C is strongly cytotoxic toward a variety of cancer-cell lines in vitro but not to normal cells. Furthermore, Fe─NCl─C shows an outstanding specific therapeutic effect in vivo; it efficiently destroys solid malignant tumors without injuring normal tissue. Altogether, these findings highlight the selective catalytic decomposition of HO to •OH, which is achieved by engineering the active center on the atomic level, thereby providing an avenue for the development of specific nanomedicines with efficient antitumor activities.

摘要

内源性 HO 通过纳米酶的干预为肿瘤特异性治疗提供了一种潜在的方法;然而,纳米酶结构与 HO 选择性分解为羟基自由基(•OH)的关系尚未得到充分理解,这限制了这种治疗方法的发展。本文报道了一种铁单原子纳米酶(Fe─NCl─C SAzyme),它是通过基于特征含 Fe 分子构建的精确 Fe─Cl 配位来制备的。Fe─NCl─C 表现出高效的 HO 分解(2.19 × 10 mm s),这在报道的 SAzymes 中是最高的。更重要的是,发现 HO 在 Fe─NCl─C 表面上选择性分解为•OH,这归因于 Fe 活性中心的 d 轨道与吸附的氢氧根(*OH)中间体的 O-2p 电子匹配。Fe─NCl─C 在体外对多种癌细胞系具有强烈的细胞毒性,但对正常细胞没有毒性。此外,Fe─NCl─C 在体内表现出出色的特异治疗效果;它能够有效地破坏实体恶性肿瘤而不损伤正常组织。总之,这些发现强调了通过在原子水平上工程化活性中心来选择性地催化 HO 分解为•OH,为开发具有高效抗肿瘤活性的特异性纳米药物提供了一种途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验